Overview

EVALUATION OF THE COMBINATION OF ANTIOXIDANTS METIONAC FOR THE MODULATION OF METABOLIC AND ENDOCRINE PARAMETERS IN PATIENTS WITH PCOS: A PROSPECTIVE RANDOMIZED STUDY

Status:
Completed

Trial end date:
2022-02-02

Target enrollment:

Participant gender:

Summary

Evaluate the efficacy of the combination of antioxidants ALA, NAC, Vit. B6 and SAMe as a dietary supplement, in the improvement of metabolic and endocrine parameters and clinical manifestations of PCOS.

Phase:

Phase 4

Details

Lead Sponsor:

Margan Biotech

Collaborator:

Grupo CINUSA (Centros de Investigación en Nutrición y Salud S.L.)

Treatments:

Contraceptive Agents
Contraceptives, Oral